[Risk assessment of development and recurrence of urolithiasis in obese patients]
- PMID: 40377566
[Risk assessment of development and recurrence of urolithiasis in obese patients]
Abstract
Urolithiasis is one of the most common urologic diseases. One of its risk factors is obesity, which is supported by the meta-analyses. The development of screening programs to predict the risk of urinary stone disease or its recurrence in obese patients is a relevant issue. We searched PubMed for literature published between 2014 and 2024 using the search terms "kidney stone," "recurrence," "predictors," and "obesity." Eight original studies were included in our study. The most significant predictors of urinary stone disease or its recurrence in obese patients were Ae index, VAI, dietary patterns, and chronic urinary tract infection. However, described models do not take into account all the factors, which are involved in pathogenesis of urinary stone disease in obese patients. Therefore, it is necessary to carry out further research, develop a single standardized diagnostic scale taking into account the results of the aforementioned studies and studied parameters, test and validate this tool for further implementation in clinical practice.
Keywords: body mass index; obesity; recurrence predictors; urinary stone disease.
Similar articles
-
Obesity and urolithiasis: evidence of regional influences.Urolithiasis. 2017 Jun;45(3):271-278. doi: 10.1007/s00240-016-0908-3. Epub 2016 Aug 3. Urolithiasis. 2017. PMID: 27488444
-
Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.J Urol. 2008 Feb;179(2):570-4. doi: 10.1016/j.juro.2007.09.040. Epub 2007 Dec 21. J Urol. 2008. PMID: 18078957
-
Obesity and BMI score as risk factors for urolithiasis: a systematic review over 30 years.Curr Opin Urol. 2025 Jul 1;35(4):338-346. doi: 10.1097/MOU.0000000000001298. Epub 2025 May 5. Curr Opin Urol. 2025. PMID: 40325962
-
Effect of obesity and metabolic health on urolithiasis: A nationwide population-based study.Investig Clin Urol. 2022 Jan;63(1):63-70. doi: 10.4111/icu.20210332. Investig Clin Urol. 2022. PMID: 34983124 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical